ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2155

Direct Comparison of Sleep Quality and Risk Factors for Poor Sleep Across Rheumatoid Arthritis, Axial Spondyloarthritis and Psoriatic Arthritis

Dagna Polak1, Mateusz Wilk2, Piotr Kuszmiersz1, Glenn Haugeberg3, Mariusz Korkosz4 and Zofia Guła4, 1University Hospital in Cracow, Kraków, Poland, 2Univesity Hospital in Cracow, Kraków, Poland, 3Sørlandet Hospital, Kristiansand, Kristiansand, Norway, 4Department of Rheumatology and Immunology, Jagiellonian University Medical College, Kraków, Poland

Meeting: ACR Convergence 2024

Keywords: Patient reported outcomes, Psoriatic arthritis, rheumatoid arthritis, sleep, spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Patient Outcomes, Preferences, & Attitudes Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Sleep disorders are common among patients with inflammatory arthritis (IA) and have probably bilateral influence on disease activity and quality of life. Pathomechanism of sleep impairment is complex and may differ among patients with RA, axSpA and PsA. Our research offers a novel direct comparison of sleep quality and risk factors for poor sleep in these three most common forms of IA.

Methods: Cross sectional study of real-world data of 319 adult IA patients from PolNorRHEUMA registry utilizing GoTreatIT software. Variables obtained during routine outpatient visits included demographics, ESR, CRP, swollen and tender joint count, global pain, back pain at night, fatigue and disease activity scores: DAS28-CRP for RA, BASDAI for axSpA and DAPSA for PsA. Sleep quality was assessed using Pittsburgh Sleep Quality Index (PSQI) and scores higher than 5 were identified as poor sleep. All patients completed the Multidimensional Health Assessment Questionnaire (MDHAQ). Statistics included ANOVA with post-hoc (Tukey), Chi-square, and multivariable adjusted linear regression (enter procedure).

Results: We included 134 RA, 105 axSpA and 80 PsA patients. Patient characteristic is shown in Table 1. Prevalence of poor sleep varied from 53,8% in PsA, 56% in RA, to 66% in axSpA. No significant differences in consecutive sleep domains were identified (Table 2). However, we found slightly different independent risk factors for poor sleep as measured in PSQI (Table 3), namely higher BMI and increased level of CRP in RA and back pain at night in axSpA and PsA. Additional factors included female gender in axSpA and older age in PsA. In the baseline linear regression model, other variables such as SJC28, TJC28, and specific HAQ components (anxiety, depression, fatigue) were initially included as covariates. However, due to significant multicollinearity, we decided to remove them from the final model used in the analysis. We also found good correlation coefficients between the specific HAQ component related to sleep quality and PSQI score: 0.59 for RA (p< 0.01), 0.57 for axSpA (p< 0.01), and 0.65 for PsA (p< 0.01).

Conclusion: Our research confirms high prevalence of sleep disturbances in RA, axSpA and PsA, without differences in particular sleep domains but different independent risk factors for poor sleep. The HAQ component related to sleep quality could serve as a potential screening tool for identifying patients who may benefit from further sleep quality evaluation.

Supporting image 1

Table 1

Supporting image 2

Table 2

Supporting image 3

Table 3

Disclosures: D. Polak: None; M. Wilk: None; P. Kuszmiersz: None; G. Haugeberg: None; M. Korkosz: None; Z. Guła: None.

To cite this abstract in AMA style:

Polak D, Wilk M, Kuszmiersz P, Haugeberg G, Korkosz M, Guła Z. Direct Comparison of Sleep Quality and Risk Factors for Poor Sleep Across Rheumatoid Arthritis, Axial Spondyloarthritis and Psoriatic Arthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/direct-comparison-of-sleep-quality-and-risk-factors-for-poor-sleep-across-rheumatoid-arthritis-axial-spondyloarthritis-and-psoriatic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/direct-comparison-of-sleep-quality-and-risk-factors-for-poor-sleep-across-rheumatoid-arthritis-axial-spondyloarthritis-and-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology